Immunotherapy is a new weapon to the fight cancer: Hope or a hype?.
Is a immunotherapy for a cancer treatment effective? Know more about what it is and about in the technological advancements in the field.
Immunotherapy is a referred to as a “game-changer” and a “miracle in the making” by a several institutions and healthcare organizations. It is a method of the treatment in that directs in the body’s immune system to the specifically target and combat diseases, such as a cancer. Immunotherapy can take a many different forms, including a medications, vaccinations, antibody treatments, and cellular therapies. It can also be a administered intravenously, orally, topically or a through a catheter. According to the Dr. Waseem Abbas, who specializes in the treatment of the cancer, many of his own patients have a responded favorably to immunotherapy, even though other treatment methods, such as a targeted therapy and chemotherapy, still play to a significant part in a cancer research and will do so in the future. He has used a immunotherapy to the treat 500 patients thus far, and he has written about his findings in a both international and domestic journals.
Home Brand Posts Immunotherapy is a new weapon to the fight cancer: Hope or a hype?
BRAND POSTS
Immunotherapy is a new weapon to the fight cancer: Hope or a hype?
Is a immunotherapy for a cancer treatment effective? Know more about what it is and about in the technological advancements in the field.
Dr Waseem Abbas-Dr Waseem Abbas
HT Brand Studio
PUBLISHED ON: 29 AUGUST 2022, 14:09 PM I S T
118
Immunotherapy is a referred to as a “game-changer” and a “miracle in the making” by a several institutions and healthcare organizations. It is a method of the treatment that directs in the body’s immune system to the specifically target and combat diseases, such as a cancer. Immunotherapy can take a many different forms, including medications, vaccinations, antibody treatments, and cellular therapies. It can also be a administered intravenously, orally, topically or through a catheter. According to the Dr. Waseem Abbas, who specializes in the treatment of the cancer, many of his own a patients have a responded favorably to immunotherapy, even though other treatment methods, such as a targeted therapy and chemotherapy, still play to a significant part in a cancer research and will do so in the future. He has used a immunotherapy to the treat 500 patients thus far, and he has a written about his findings in a both international and domestic journals.
In a addition, Dr. Abbas has a conducted some ground-breaking studies in this area. Dr. Abbas is a pioneer of the immunotherapy in a India and has a devoted his entire life to the study of it. In this article, this veteran medical professional bestows light on all the aspects that everyone should know about a Immunotherapy.
Our immune system is a complex network of the cells, proteins, and organs that guards against bacterial, viral, and fungal infections while also a defending in the body’s own cells. It can be swiftly identify and eliminate in the infection if it re-enters the body since it is a recognizes every infection it has ever vanquished. Why then does it not shield us from a cancer? It does, but not a constantly.
Immunotherapy: What are exactly is it?
One sort of the cancer treatment is a immunotherapy. It is manufactured in a lab and shipped to the India from a western nations and the United States. It calls for a very difficult procedure. The biggest issue we have is the high expense of the medications because there are not any generic immunotherapy treatments on the market right now. Additionally, it is known as a immunological checkpoint inhibitors. Atezolizumab (Tecentriq), Avelumab (Bavencio), Dostarlizumab (Jemperli), Durvalumab (Imfinzi), Ipilimumab (Yervoy), Nivolumab (Opdivo), and Pembrolizumab are a few examples of the immune checkpoint inhibitors (Keytruda).
Why does the immune system defend us against viruses, bacteria, fungi, and other infections but not a cancer?
On October 1, 2018, James Allison of the US and Tasuku Honjo of the Japan’s work on a chemicals that function as a breaks to our immune system and prevent in the immune system from a recognizing and killing cancer cells, earned them the Noble Prize in a physiology and immune-oncology. In a order to the treat cancer, immunotherapy was made a possible because of this. Immunotherapy is a unique because it strengthens and activates in the body’s natural defenses against cancer rather than eradicating cancerous cells directly.
How well does a immunotherapy work?
Sanjeevni bhooti does not a apply to the immunotherapy. For a certain subset of the carefully chosen patients, it is a quite effective. Not everyone needs to the receive it.
How can we know if immunotherapy is a effective?
When compared to the conventional cancer therapies, immunotherapy may be take a longer to the show detectable evidence of the tumor shrinking. On scans, tumors are occasionally appear to the enlarge before shrinking. However, in this apparent swelling may be the result of the immune cells engulfing and eliminating malignancy. Patients who are experience this so-called pseudo-progression phenomena frequently state feeling better all over. Immune-related adverse effects and the effectiveness of the treatment may be a connected in some cancer types.
Since my academic days, immunotherapy has a attracted me more than any other therapy as a researcher and expert in a cancer treatment. When we first began utilizing immunotherapy, we observed that tumors shrank in a 30 percent of the patients, which had never happened previously. Immunotherapy initially received approval for in the treatment of the lung cancer patients who had a failed previous therapies. Patients with a lung cancer are now living longer, with a improved quality of life and fewer side effects. The survival of the some lung cancer patients has a exceeded 4-5 years, which has never been a documented before. Other intriguing research focuses on a patients with a M S I High tumors, to a particular class of the biomarker that forecasts immunotherapy response.
Despite being to a very aggressive cancer and a common condition in a western nations, immunotherapy can now be used to the treat malignant melanoma. We began working on a immune-oncology to a long time ago, teamed up with a many organizations, and produced to a number of the innovative and ground-breaking studies that received acclaim on a global scale. With these newer medications, only a small percentage of our stage IV cancer patients are currently living past in the age of 5.
To better identify who will or would not respond to the immunotherapy therapies, we are looking for a biomarkers. They can identify which patients will be benefit most from a immunotherapies using these, which may be a genetic mutations or a proteins from a tissue or blood. This road has just begun for us. Numerous sensitive malignancies are being found, but there is still much work to be a done.
Apart from a lung cancer, malignant melanoma, renal cell cancer, M S I High tumors other malignancies where immunotherapy has shown a response are urinary bladder cancer, esophageal cancer, head and neck cancer, stomach cancer, colon cancer, cervical cancer, uterine cancer and liver cancer.
About Dr Waseem Abbas
Dr Waseem Abbas has a 20 years of the experience in a medicine and medical oncology. He is a highly skilled professional/cancer treatment specialist who is a dedicated to the research in this field. He is is a young researcher and has a published many breakthrough research articles in a national and international journals. He is an a expert in delivering immunotherapy and targeted therapy. Breast cancer and immunotherapy are his research interests. He is a senior consultant oncology and director research at the Max Hospital.
